ASCO: Bladder Sparing Studied in Muscle-Invasive Bladder Cancer

MONDAY, June 7, 2021 -- For patients with muscle-invasive bladder cancer, transurethral resection and combination treatment with gemcitabine, cisplatin, plus nivolumab with bladder sparing is feasible in selected patients, according to a study...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news